Pipeline

Cellis aim is to create a leading cell-based technology company. We have a patient-oriented mission to deliver ground-breaking treatment strategies to patients with solid tumors of unmet medical need.

We are advancing a fully owned and patented pipeline of autologous and allogeneic MDC product candidates.

Candidate
Exploratory
Research
Pre-Clinical PoC
IND enabling
MDC-735
MDC-250
MDC-2135
MDC-353